Carl Zeiss Meditec AG · ISIN: DE0005313704 · EQS - Company News

Carl Zeiss Meditec achieves slight revenue growth in first quarter of 2023/24

Carl Zeiss Meditec achieves slight revenue growth in first quarter of 2023/24  Decline in profit due to expected weaker product mix   JENA, 9 February 2024 Carl Zeiss Meditec generated revenue of €475.0m in the first quarter of fiscal year 2023/24 (prior year: €470.3m), corresponding to a growth of +1.0% (adjusted for currency effects: +3.3%). Order backlog normalized to around €315m. Earnings before interest and taxes (EBIT) declined to around €43.5m (prior year: €60.3m). The EBIT margin ...

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

Corporate News Carl Zeiss Meditec AG

In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
Back to Corporate News Overview
This might be interesting for you as well
09 February 2024 07:00AM
Carl Zeiss Meditec achieves slight revenue growth in first quarter of 2023/24
Carl Zeiss Meditec achieves slight revenue growth in first quarter of 2023/24  Decline in profit due to expected weaker product mix   JENA, 9 February 2024 Carl Zeiss Meditec generated revenue of €475.0m in the first quarter of fiscal year 2023/24 (prior year: €470.3m), corresponding to a growth of +1.0% (adjusted for currency effects: +3.3%)...
Carl Zeiss Meditec AG
29 January 2024 11:11AM
Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150m
   Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150m Jena, 29 January 2024 The Management Board of Carl Zeiss Meditec AG (ISIN: DE0005313704) has, with the approval of the Supervisory Board today, agreed to launch a share buyback program. Under the share buyback program, own shares will be purchased f...
Carl Zeiss Meditec AG
11 January 2024 01:00PM
U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS
U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS   The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements. DUBLIN, CA (USA) / JENA, Germany | January 11, 2024 | Carl Zeiss Meditec AG ZEISS Medical Technology announced today tha...
Carl Zeiss Meditec AG
15 December 2023 05:53PM
Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)
Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)Acquisition will extend the company’s leadership in ophthalmic medical devices market and expands its position in the vitreo-retinal surgery segment   Jena/Deutschland | Dec. 15, 2023 | Carl Zeiss Meditec AG   Carl Zeiss Meditec AG announced today t...
Carl Zeiss Meditec AG
15 December 2023 05:43PM
Carl Zeiss Meditec AG announces agreement to acquire D.O.R.C.
 Carl Zeiss Meditec AG announces agreement to acquire D.O.R.C.   Jena, December 15, 2023 Carl Zeiss Meditec AG (ISIN: DE0005313704) announces today that it has entered into a definitive agreement to acquire 100% of the shares in Dutch Ophthalmic Research Center (International) BV, Zuidland, Netherlands (D.O.R.C.), from the investment firm ...
Carl Zeiss Meditec AG
12 December 2023 07:00AM
Carl Zeiss Meditec increased revenue in fiscal year 2022/23 by around 10 percent
Carl Zeiss Meditec increased revenue in fiscal year 2022/23 by around 10 percent  Additional market shares were gained despite challenging macroeconomic conditions   JENA, 12 December 2023   Carl Zeiss Meditec generated revenue of €2,089m in fiscal year 2022/23 (prior year: €1,903m), corresponding to growth of +9.8% (adjusted for currency ef...
Carl Zeiss Meditec AG
04 August 2023 07:00AM
Carl Zeiss Meditec achieves further strong revenue growth after nine months of fiscal year 2022/23 with continued high strategic investments
Carl Zeiss Meditec achieves further strong revenue growth after nine months of fiscal year 2022/23 with continued high strategic investments JENA, 4 August 2023 Carl Zeiss Meditec generated revenue of around €1,509.6m in the first nine months of fiscal year 2022/23 (prior year: €1,332.9m) - growth of +13.3% (adjusted for currency effects: +12.9%...
Carl Zeiss Meditec AG
09 May 2023 07:00AM
Carl Zeiss Meditec achieves double-digit growth in first half year of 2022/23 with declining earnings
Carl Zeiss Meditec achieves double-digit growth in first half year of 2022/23 with declining earnings  Unfavorable product mix and increase in operating costs impact EBIT margin   JENA, 9 May 2023 Carl Zeiss Meditec generated revenue of around €974.5m in the first six months of fiscal year 2022/23 (prior year: €855.4m), equating to growth of ...
Carl Zeiss Meditec AG
09 May 2023 07:00AM
Carl Zeiss Meditec achieves double-digit growth in first half year of 2022/23 with declining earnings
Carl Zeiss Meditec achieves double-digit growth in first half year of 2022/23 with declining earnings  Unfavorable product mix and increase in operating costs impact EBIT margin   JENA, 9 May 2023 Carl Zeiss Meditec generated revenue of around €974.5m in the first six months of fiscal year 2022/23 (prior year: €855.4m), equating to growth of ...
Carl Zeiss Meditec AG
19 April 2023 10:24AM
Forecast for fiscal year 2022/23 refined – Targeting widened and reduced range for EBIT margin – Further growth with reduced earnings in first half year of 2022/23
Forecast for fiscal year 2022/23 refined – Targeting widened and reduced range for EBIT margin – Further growth with reduced earnings in first half year of 2022/23   Jena, April 19, 2023 In the first half of fiscal year 2022/23, Carl Zeiss Meditec AG (ISIN: DE0005313704) had revenues of € 974.5 million (prior year: € 855.4 million). Operati...
Carl Zeiss Meditec AG
19 April 2023 10:24AM
Forecast for fiscal year 2022/23 refined – Targeting widened and reduced range for EBIT margin – Further growth with reduced earnings in first half year of 2022/23
Forecast for fiscal year 2022/23 refined – Targeting widened and reduced range for EBIT margin – Further growth with reduced earnings in first half year of 2022/23   Jena, April 19, 2023 In the first half of fiscal year 2022/23, Carl Zeiss Meditec AG (ISIN: DE0005313704) had revenues of € 974.5 million (prior year: € 855.4 million). Operati...
Carl Zeiss Meditec AG
10 February 2023 07:00AM
Carl Zeiss Meditec achieves further revenue growth in Q1 2022/23 – Orders on hand remain high
Carl Zeiss Meditec achieves further revenue growth in Q1 2022/23 – Orders on hand remain high   Weaker product mix and high investments burden development of operating profit at start of the year   JENA, 10 February 2023   Carl Zeiss Meditec generated revenue of €470.3m in the first quarter of fiscal year 2022/23 (prior year: €410.2m), co...
Carl Zeiss Meditec AG
10 February 2023 07:00AM
Carl Zeiss Meditec achieves further revenue growth in Q1 2022/23 – Orders on hand remain high
Carl Zeiss Meditec achieves further revenue growth in Q1 2022/23 – Orders on hand remain high   Weaker product mix and high investments burden development of operating profit at start of the year   JENA, 10 February 2023   Carl Zeiss Meditec generated revenue of €470.3m in the first quarter of fiscal year 2022/23 (prior year: €410.2m), co...
Carl Zeiss Meditec AG
09 December 2022 07:00AM
Carl Zeiss Meditec remains on growth course in fiscal year 2021/22
  Carl Zeiss Meditec remains on growth course in fiscal year 2021/22   High revenue and strong order situation in spite of persistent geopolitical and macroeconomic risks   JENA, 9 December 2022   Carl Zeiss Meditec generated revenue of around €1,903m in fiscal year 2021/22 (prior year: €1,647m), corresponding to growth of +15.5% (adjusted...
Carl Zeiss Meditec AG
09 December 2022 07:00AM
Carl Zeiss Meditec remains on growth course in fiscal year 2021/22
  Carl Zeiss Meditec remains on growth course in fiscal year 2021/22   High revenue and strong order situation in spite of persistent geopolitical and macroeconomic risks   JENA, 9 December 2022   Carl Zeiss Meditec generated revenue of around €1,903m in fiscal year 2021/22 (prior year: €1,647m), corresponding to growth of +15.5% (adjusted...
Carl Zeiss Meditec AG
05 August 2022 07:00AM
Carl Zeiss Meditec achieves further significant growth in revenue and order intake after nine months of 2021/22
Carl Zeiss Meditec achieves further significant growth in revenue and order intake after nine months of 2021/22  JENA, 5 August 2022 Carl Zeiss Meditec generated revenue of €1,332.9m in the first nine months of fiscal year 2021/22 (prior year: €1,198.2m), corresponding to an increase of 11.2% (adjusted for currency effects: +9.8%) compared with ...
Carl Zeiss Meditec AG
05 August 2022 07:00AM
Carl Zeiss Meditec achieves further significant growth in revenue and order intake after nine months of 2021/22
Carl Zeiss Meditec achieves further significant growth in revenue and order intake after nine months of 2021/22  JENA, 5 August 2022 Carl Zeiss Meditec generated revenue of €1,332.9m in the first nine months of fiscal year 2021/22 (prior year: €1,198.2m), corresponding to an increase of 11.2% (adjusted for currency effects: +9.8%) compared with ...
Carl Zeiss Meditec AG
13 May 2022 07:00AM
Carl Zeiss Meditec achieves further significant growth in revenue and order intake in first half 2021/22
Carl Zeiss Meditec achieves further significant growth in revenue and order intake in first half 2021/22 Strained supply chain situation in equipment business continues   JENA, 13 May 2022 Carl Zeiss Meditec generated revenue of €855.4m in the first six months of fiscal year 2021/22 (prior year: €767.4m), corresponding to an increase of 11.5...
Carl Zeiss Meditec AG
19 April 2022 04:00PM
Carl Zeiss Meditec acquires two manufacturers of surgical instruments
Carl Zeiss Meditec acquires two manufacturers of surgical instruments   Carl Zeiss Meditec announced today the acquisition of two manufacturers of surgical instruments (Kogent Surgical, LLC and Katalyst Surgical, LLC) to further strengthen its positioning as a solution provider   Jena/Germany | 19 April 2022 Kogent Surgical and Katalyst Sur...
Carl Zeiss Meditec AG
11 February 2022 07:00AM
Carl Zeiss Meditec achieves further growth in first quarter of 2021/22
Carl Zeiss Meditec achieves further growth in first quarter of 2021/22   Revenue up by around 11% year-on-year in first three months 2021/22, orders received grow by 24%   JENA, 11 February 2022 Carl Zeiss Meditec generated revenue of €410.2m in the first three months of fiscal year 2021/22 (prior year: €368.9m), corresponding to an incre...
Carl Zeiss Meditec AG
10 December 2021 07:00AM
Record revenue for Carl Zeiss Meditec in fiscal year 2020/21
Record revenue for Carl Zeiss Meditec in fiscal year 2020/21   Major innovations launched in ophthalmic surgery and digitization   JENA, 10 December 2021 Carl Zeiss Meditec generated revenue of approximately €1,647m in fiscal year 2020/21 (prior year: €1,336m), corresponding to growth of +23.3% (adjusted for currency effects: +26.5%). Ord...
Carl Zeiss Meditec AG
30 September 2021 05:00PM
Change to Executive Board of Carl Zeiss Meditec AG
Change to Executive Board of Carl Zeiss Meditec AG President and CEO Dr. Ludwin Monz will be stepping down from the Executive Board of Carl Zeiss Meditec AG at his own request and by amicable agreement on 31 December 2021. He will be succeeded by Dr. Markus Weber effective 1 January 2022. Dr. Weber is currently a member of the Executive Board of...
Carl Zeiss Meditec AG
30 September 2021 04:20PM
Leadership Change in the Executive Board of Carl Zeiss Meditec AG
Leadership Change in the Executive Board of Carl Zeiss Meditec AG Jena, September 30, 2021 The Supervisory Board of Carl Zeiss Meditec AG (ISIN: DE0005313704) has agreed on a change in the Executive Board of the company. Dr. Ludwin Monz, who has been Chief Executive Officer of the company since 2010, will turn over his position to Dr. Mark...
Carl Zeiss Meditec AG
06 August 2021 07:00AM
Carl Zeiss Meditec records significant increase in revenue and raises annual targets
Carl Zeiss Meditec records significant increase in revenue and raises annual targets   Acceleration of growth in both strategic business units with good contributions from all reporting regions   JENA, 6 August 2021 Carl Zeiss Meditec generated revenue of €1,198.2m in the first nine months of fiscal year 2020/21 (prior year: €967.9m), gr...
Carl Zeiss Meditec AG
16 July 2021 11:39AM
Carl Zeiss Meditec AG continues its growth after nine months 2020/21 and raises targets for fiscal year
  Carl Zeiss Meditec AG (ISIN: DE0005313704) has achieved revenue of EUR 1,198.2 million after nine months of fiscal year 2020/21 (past year: EUR 967.9 million). This corresponds to a revenue development of +23.8% vs. the past year (after adjustment for currency effects[1]: +27.6%). In the third quarter of FY 2020/21, revenue amounted to EUR ...
Carl Zeiss Meditec AG
10 May 2021 07:00AM
Carl Zeiss Meditec returns to significant revenue growth in H1 2020/21
Carl Zeiss Meditec returns to significant revenue growth in H1 2020/21   Strong increase in operating profit due to low costs   JENA, 10 May 2021 Carl Zeiss Meditec generated revenue of €767.4m in the first six months of fiscal year 2020/21 (prior year: €714.9m), an increase of +7.3% (adjusted for currency effects: +10.5%). Earnings befor...
Carl Zeiss Meditec AG
19 April 2021 10:06AM
Carl Zeiss Meditec AG returns to significant revenue growth in second quarter 2020/21
Carl Zeiss Meditec AG returns to significant revenue growth in second quarter 2020/21 Jena, April 19, 2021 Carl Zeiss Meditec AG (ISIN: DE0005313704) has achieved revenue of EUR 767.4 million in the first half of fiscal year 2020/21 (previous year: EUR 714.9 million). This corresponds to a revenue development of +7.3% vs. the past year (af...
Carl Zeiss Meditec AG
19 January 2021 09:54AM
Carl Zeiss Meditec AG achieves increase in profit in first quarter 2020/21
Carl Zeiss Meditec AG achieves increase in profit in first quarter 2020/21 Jena, January 19, 2021 Carl Zeiss Meditec AG (ISIN: DE0005313704) has achieved revenue of EUR 368.9 million in the first quarter of fiscal year 2020/21 (previous year: EUR 369.7 million). This corresponds to a revenue development of -0.2% vs. the past year (after adjust...
Carl Zeiss Meditec AG
11 December 2020 07:00AM
Carl Zeiss Meditec reports decline in revenue due to COVID-19 pandemic
Carl Zeiss Meditec reports decline in revenue due to COVID-19 pandemic   Recurring Revenue stable overall   JENA, 11 December 2020 Carl Zeiss Meditec generated revenue of €1,335.5m in fiscal year 2019/20 (prior year: €1,459.3m), a decline of -8.5% (adjusted for currency effects: -8.7%) year on year. Earnings before interest and taxes (EBI...
Carl Zeiss Meditec AG
29 October 2020 02:04PM
Carl Zeiss Meditec AG concludes fiscal year 2019/20 with a recovery in profit in fourth quarter - outlook remains uncertain due to COVID-19 pandemic
Carl Zeiss Meditec AG concludes fiscal year 2019/20 with a recovery in profit in fourth quarter - outlook remains uncertain due to COVID-19 pandemic Jena, October 29, 2020 Carl Zeiss Meditec AG (ISIN: DE0005313704) has achieved revenue of approximately EUR 1,335.5 million in fiscal year 2019/20 (previous year EUR 1,459.3 million) and has there...
Carl Zeiss Meditec AG
05 August 2020 07:00AM
Carl Zeiss Meditec reports decline in revenue due to COVID-19 pandemic
Carl Zeiss Meditec reports decline in revenue due to COVID-19 pandemic   Revenue lower by around 6% year-on-year after nine months 2019/20   JENA, 5 August 2020 Carl Zeiss Meditec generated revenue of €967.9m in the first nine months of fiscal year 2019/20 (prior year: €1,027.6m), a decline of -5.8% (adjusted for currency effects: -6.9%) ...
Carl Zeiss Meditec AG
More Carl Zeiss Meditec AG related information
Type Total Last Made by Go to
Corporate Research 0 - - Corporate Research
Directors Dealings 0 - - DD
Short Seller (DE) 4 18th June 2024 Millennium International Management LP SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

v.07062023 EN